Encapsulation Agent Articles & Analysis
11 news found
These nanoparticles offer the unique advantage of encapsulating various therapeutic agents, protecting the active substances from degradation, and improving their bioavailability. ...
Microspheres are tiny spherical particles that allow for controlled drug release, ensuring a sustained therapeutic effect over an extended period of time. By encapsulating pharmaceutical agents within these microspheres, CD Formulation enables precise dosage delivery, which can help reduce the frequency of drug administration. ...
” Andrew Bright, President and CEO of C4 Imaging commented, “Orion, C4 Imaging’s Positive Signal HDR MRI Marker, which is based on the encapsulation of C4, our unique MRI agent, allows accurate positive-signal MRI treatment planning to be offered to cancer patients suitable for HDR treatment. ...
“The approval of an additional Radiation Oncology product based on the encapsulation of our unique MRI agent allows accurate positive-signal MRI treatment planning to be offered to all cancer patients suitable for HDR ...
Future success of LAUR-301 is expected to provide an effective new treatment for ALS patients. V-Smart® Nanomedicines encapsulate and deliver non-brain penetrant therapeutic agents across the blood brain barrier (BBB) and into the central nervous system (CNS) after non-invasive administration. ...
"We are excited about the potential of LAUR-401. Many anti-cancer agents have shown potential for GBM, but, since they can neither cross the brain, by existing oral or i.v. administration, nor target GBM cells, they fall short for patients. ...
"Trophic factors and other neuroprotective and regenerative agents, that do not get into brain by existing oral or i.v. delivery, have shown potential to protect motor neurons during course of ALS. ...
About V-Smart™ Nanomedicines for Brain Diseases V-Smart™ Nanomedicines can encapsulate therapeutic agents, cross the blood brain barrier (BBB), target sites in the brain, selectively release therapeutic agents at target sites and be administered systemically. A considerable number of therapeutic agents, with the ...
"Trophic factors and other neuroprotective and regenerative agents, that do not get into the brain by existing oral or i.v. delivery, have shown potential to protect motor neurons during the course of ALS. ...
Austria 4 projects (14.5 million) LIFE+ Environment Policy and Governance (1 project – 3.6 million) LIFE-URBANLAKE (Stadt Wien – Magistratsabteilung 45 – Wiener Gewässer): This project intends to define strategies to reduce the vulnerability of the “Alte Donau” from effects of climate change and other anthropogenic pressures with the goal of securing the oxbow ...
Environmental Protection Agency (EPA) is awarding $80,000 to TDA Research, Inc., in Wheat Ridge, Colo., to develop technologies to protect public health and the environment following potential accidents or intentional attacks involving chemical and biological agents. Today’s Small Business Innovation Research (SBIR) award is among more than $2 million EPA is providing to 25 ...